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Abstract— Considering the major role of insulin signaling 
on fatty acid synthesis via stimulation of lipogenic enzymes, 
differential effects of insulin signaling on individual carbon 
fluxes for fatty acid synthesis have been investigated by 
comparing the individual lipogenic fluxes in WT and IRS-1 
knockout (IRS-1 KO) brown adipocytes.  Results from 
experiments on WT and IRS-1 KO cells incubated with [5-
13C] glutamine were consistent with the existence of reductive 
carboxylation pathway.  Analysis of isotopomer distribution 
of nine metabolites related to the lipogenic routes from 
glucose and glutamine in IRS-1 KO cells using [U-13C] 
glutamine as compared to that in WT cells indicated that flux 
through reductive carboxylation pathway was diminished 
while flux through conventional TCA cycle was stimulated 
due to absence of insulin signaling in IRS-1 KO cells.  This 
observation was confirmed by quantitative estimation of 
individual lipogenic fluxes in IRS-1 KO cells and their 
comparison with fluxes in WT cells.  Thus, these results 
suggest that glutamine’s substantial contribution to fatty acid 
synthesis can be directly manipulated by controlling the flux 
through reductive carboxylation of alpha-ketoglutarate to 
citrate using hormone (insulin). 
 
Index Terms — brown adipocyte, fatty acid synthesis, 
insulin signaling, and reductive carboxylation pathway 
I. INTRODUCTION 
OBESITY and type II diabetes are among the most widespread and high-cost epidemics with rapid 
increase in the incidents for the last decade.  There have 
been evidences that excessive fat synthesis in obesity may 
give rise to elevated free fatty acids, which in turn could 
lead to hepatic insulin resistance, one of the major early 
events of type II diabetes [1].  Therefore, understanding the 
detailed mechanism of regulation for fat synthesis and its 
relationship with insulin signaling may provide insights 
into the pathogenesis of the two diseases and help 
preventing them. 
Insulin signaling has long been associated with elevating 
overall lipogenic activity through increased activity of 
lipogenic enzymes [2].  Evidences have been accumulated 
that many of these enzymes are stimulated directly by 
insulin signaling via insulin response element at their 
transcription level or indirectly by insulin signaling to 
transcription factors [3].  However, studies on stimulation 
of lipogenic enzymes’ activity by insulin signaling have 
been largely limited to the enzymes directly related to 
glucose’s metabolic route to fatty acid synthesis, namely 
 
Fig. 1.  Two pathways for glutamine’s metabolic route to fatty acid synthesis.
A. Glutaminolysis pathway.  Glutamine enters TCA cycle at α-ketoglutarate
and converted to succinate, fumarate, and malate, whose further conversion
to pyruvate and acetyl-CoA leads to fatty acid synthesis.    B. Reductive
carboxylation pathway.  Glutamine enters TCA cycle at α-ketoglutarate,
which is directly converted to isocitrate and citrate via reductive
carboxylation and cleaved to supply acetyl-CoA for fatty acid synthesis.  
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glucose transporter, glucokinase, glyceraldehyde-3-
phosphate dehydrogenase, ATP-citrate lyase, acetyl-CoA 
carboxylase, fatty acid synthase, and malic enzyme (as 
supplier of NADPH for fatty acid synthesis).  The effect of 
insulin on enzymes for lipogenic utilization of other carbon 
sources has been neglected because their contribution was 
thought to be minimal.  Moreover, analysis of the lipogenic 
fluxes from glucose to fatty acid synthesis has been 
qualitative, examining only the overall lipogenic activity 
and not the individual fluxes. 
Among alternative carbon sources for lipogenesis, 
glutamine has attracted some attention because its 
considerable contribution to lipogenesis in many 
mammalian tissues was shown by significant incorporation 
of 14C-label from 14C-glutamine into triglyceride [4-6].  In 
wild-type brown adipocytes, glutamine’s contribution to de 
novo synthesis of fatty acids has been shown to be higher 
than that of glucose in our previous report [7].  In this 
report, we also showed that in insulin receptor substrate-1 
knockout (IRS-1 KO) brown adipocytes glutamine’s 
fractional contribution to fatty acid synthesis was much 
lower than that of glucose.  It has been demonstrated that 
phosphatidylinositol 3-kinase (PI3K)-mediated insulin-
signaling pathway was greatly impaired in IRS-1 KO 
brown adipocytes [8][9].  Thus, utilization of glutamine as 
lipogenic carbon source may be regulated by insulin 
signaling to a stronger extent than that of glucose in brown 
adipocytes.  
In this study, the two possible pathways for glutamine’s 
metabolic route to fatty acid synthesis (Fig. 1) have been 
examined in both WT and IRS-1 KO brown adipocytes by 
[5-13C] glutamine.  Using the isotopomer distribution data 
for nine lipogenesis-related metabolites from incubation 
with [U-13C]-labeled glutamine, we have quantitatively 
analyzed the individual fluxes that make up the lipogenic 
routes from glucose and glutamine as two major carbon 
sources in WT and IRS-1 KO brown adipocytes.  
Comparison of individual fluxes in WT and IRS-1 KO cells 
confirmed the importance of glutamine as lipogenic carbon 
source in brown adipocytes.  Moreover, the potential sites 
for regulating glutamine’s lipogenic flux by insulin 
signaling were identified.   
 
II. EXPERIMENTAL PROCEDURES 
 
 
Fig. 1.  Metabolic network scheme to distinguish the two pathways for glutamine’s route to fatty acid synthesis, using [5-13C] glutamine. 
If glutamine follows glutaminolysis pathway, 13C-label at C-5 of glutamine will be found in either of the two terminal carbons of succinate
because of its symmetry.  Both 13C-labels will then be lost as CO2 when malate is converted to pyruvate and acetyl-CoA.  13C-labels on the two
terminal carbons of oxaloacetate will not be transferred to acetyl-CoA when citrate is cleaved back to oxaloacetate plus acetyl-CoA, because of the
stereospecificity of ATP-citrate lyase.  If glutamine follows reductive carboxylation pathway, 13C-label at C-5 of glutamine will be maintained at
acetyl-CoA side of the terminal carbon of citrate.  When citrate is cleaved by ATP-citrate lyase, 13C-label is transferred to acetyl-CoA and




Biochemicals were obtained from Sigma Chemical Co., 
St. Louis, MO. 13C-labeled chemicals were obtained from 
Cambridge Isotope Laboratories, Inc., Andover, MA.  
Tissue culture media were obtained from Invitrogen, Co., 
Carlsbad, CA. 
B. Cell cultures and adipocyte differentiation  
Brown adipocyte cells were cultured with the same 
procedure as in Yoo et al. [7] Briefly, WT and IRS-1 KO 
brown preadipocytes were grown in 6-well plates (surface 
area = 10 cm2) to confluence in differentiation media 
containing 25 mM glucose, 4 mM glutamine, 20 nM 
insulin, 1 nM T3, and 10 % fetal bovine serum as well as 
44 mM NaHCO3 (day 0).  The media were then replaced 
with fresh induction media, which was differentiation 
media plus 0.125 mM indomethacin, 0.25 mM IBMX, and 
5 µM dexamethasone.  On day 2 and day 4, the media were 
replaced with fresh differentiation media to reach day 6.   
In [5-13C] glutamine experiment, the media from day 2 to 
day 6 contained 4 mM [5-13C] glutamine and 25 mM 
unlabeled glucose.  In studies for the determination of 
carbon flux from glucose or glutamine to fatty acid 
synthesis through tricarboxylic acid (TCA) cycle, on day 4 
the media were changed to differentiation media without 
glucose or glutamine at 42 hrs after day 2.  The 
differentiation media were supplemented with selected 
concentration of oxalomalate or 2-methylisocitrate and 
incubated at 37°C for 10 min, followed by addition of 
glucose and glutamine with specified 13C-labeling.  In six 
hours, cells were harvested for analysis of metabolites.   
C. Isolation and derivatization of organic/amino acids 
and lipids  
For isolation of organic/amino acids, the procedure 
described in Fiehn et al. [20] was modified as follows.  0.7 
mL methanol and 25 µL water was added to each well of 6-
well plate immediately after removal of the media.   In 15 
min after incubation at room temperature, methanol extract 
was mixed with 0.7 mL water and 0.37 mL chloroform in 
15 mL tube.  Vigorous vortexing was followed by 
centrifugation at 3000 x g for 3 min.  The chloroform layer 
was carefully removed and the methanol/water layer was 
centrifuged again at 3000 x g for 3 min.  Clear solution of 
methanol/water layer (separated from white precipitate) 
was then transferred to glass vial and evaporated.  The 
residue was dissolved in 70 µL of methoxyamine 
hydrochloride (20 mg/mL in pyridine) and vortexed.  After 
90 min incubation at 37°C, organic/amino acids were 
derivatized with 70 µL of N-methyl-N-tert-
butyldimethylsilyltrifluoroacetamide (MTBSTFA) at 70°C 
for 30 min.  The reaction mixture was then directly injected 
into GC-MS instrument for analysis of the isotopomer 
distribution of organic/amino acids.  Isolation of lipids and 
derivatization of palmitate moiety into methyl ester were 
performed as described previously [7].   
D. GC-MS for isotopomer distribution measurement  
Samples from [5-13C] glutamine experiment were 
analyzed for palmitate isotopomer distribution with the 
same instrumental setup as previously reported [7].   The 
samples from the rest of the experiments were analyzed 
with another GC-MS instrument described below.  
Isotopomer distributions of fatty acid methyl esters 
measured with the second GC-MS instrument with scan 
mode were essentially identical to those measured with the 
first GC-MS with selected ion monitoring (SIM) mode. 
Samples were injected into a Hewlett-Packard model 
5890 series II Gas Chromatograph connected to HP5971 
series Mass Selective Detector and equipped with DB-XLB 
(60 m x 0.25 mm id x 0.25 mm) capillary column (J&W 
Scientific, Folsom, CA).  Helium flow with 10 psi inlet 
pressure was maintained by electronic control.  The 
temperatures of the injector and the detector were kept at 
230°C and 300°C, respectively.  For isotopomer 
distribution analysis of methyl palmitate and its 
isotopomers (M+0 to M+16 (m/z=270 to 286)), GC column 
temperature was started at 100°C and held for 1 min.  The 
temperature was then increased to 250°C at 10°C/min, and 
held for 5 min.  It was increased to 300°C at 25°C/min and 
held for 2 min.  Mass range of 100 to 350 was recorded at 
2.7 scans per second.  For isotopomer distribution analysis 
of acid derivatives, GC temperature was started at 100°C 
and held for 5 min.  The temperature was then increased to 
300°C at 10°C/min, and held for 5 min.  Mass range of 50 
to 550 was recorded at 1.5 scans per second.  The most 
abundant fragments (M−57) of the following acid 
derivatives (tert-butyldimethylsilyl; TBDMS) were 
analyzed for their isotopomer distributions: pyruvate 
(m/z=174-178), lactate (m/z=261-265), fumarate 
(m/z=287-293), α-ketoglutarate (m/z=346-354), malate 
(m/z=419-423), aspartate (m/z=418-424), glutamate 
(m/z=432-440), and citrate (m/z=459-468).  
Uptake fluxes for glucose and glutamine into WT cells 
were calculated from the rates of consumption of glucose 
and glutamine from medium as reported previously [7].   
E. Data Analysis 
Fractional contribution of 13C-labeled carbon sources to 
fatty acid synthesis (D value) and fractional new synthesis 
of fatty acids during time t (g(t) value) were estimated with 
the isotopomer distribution measurements of palmitate 
based on the model of isotopomer spectral analysis (ISA) 
as reported previously [7].  For estimation of fluxes in the 
metabolic network model (Fig. 5) by integrating the 
isotopomer distributions of palmitate, pyruvate, lactate, 
fumarate, α-ketoglutarate, malate, aspartate, glutamate, and 
citrate, a MATLAB program was used.  Based on steady-
state assumption, the program estimates fluxes for reactions 
in the metabolic network model that fit the inputs of a 
metabolic network (consisting of a set of reactions, each 
with specific atomic transitions between defined 
metabolites) and measurements of isotopomer distributions 
of some metabolites, using least-square fit method.  Given 
 
 
measurement errors for the isotopomer distribution data, 
the program can calculate how good the fit for each 
metabolite’s measurement is and the uncertainty of each 
estimated flux. 
Glucose and glutamine taken up from medium and 
preexisting palmitate were defined as substrates, and 
production of lactate (exported into medium), palmitate, 
and protein synthesis from aspartate was treated as sink.  
The rest of the metabolites were regarded as balanced 
except for CO2, which was allowed to be unbalanced.   
The equations for the whole metabolic network were set 
up with 32 variables (fluxes).  The number of independent 
measurements for solving the equations was 50, the sum of 
“the number of isotopomers – 1” for nine metabolites.  
Each measurement of isotopomer distribution was 
corrected for natural abundance by the program before flux 
estimation. 
For each set of flux estimation results, statistical 
evaluation of how good the fit was for each metabolite’s 
isotopomer distribution was calculated in terms of sum of 
square residuals (SSRES) based on measurement errors.  
SSRES was defined as Σ (difference between data and fit / 
measurement error)2.  Overall goodness of fit was 
calculated by summing up SSRES values for all nine 
metabolites, which was compared with the range of SSRES 
values for 95% confidence calculated by the program. 
III. RESULTS 
A. [5-13C] glutamine’s contribution to palmitate 
synthesis in IRS-1 KO brown adipocytes 
 In order to assess the significance of reductive 
carboxylation pathway in glutamine’s contribution to 
palmitate synthesis in IRS-1 KO brown adipocytes [7], the 
incorporation of 13C from [5-13C] glutamine into palmitate 
synthesis was examined after 4-day incubation of WT and 
IRS-1 KO cells with 25 mM unlabeled glucose and 4 mM 
[5-13C] glutamine from day 2 to day 6.  Substantial 
incorporation of 13C from C-5 of glutamine into palmitate 
(Fig. 1) was also analyzed for fractional contribution of [5-
13C] glutamine to lipogenic acetyl-CoA by ISA model. [5-
13C] glutamine contributed 34.1 ± 0.6 % to palmitate 
synthesis in WT cells and 18.5 ± 0.1 % in IRS-1 KO cells.  
 
Fig. 3.  Differential incorporation of glutamine carbon into palmitate
synthesis in WT and IRS-1 KO cells. 
Isotopomer distribution of palmitate from WT and IRS-1 brown
adipocytes on day 4 under 6-hr incubation in media containing 25 mM
unlabeled glucose and 4 mM [U-13C] glutamine.  
B. Isotopomer distribution of nine metabolites related to 
fatty acid synthesis 
Incorporation of glutamine carbon into palmitate 
synthesis was measured for WT and IRS-1 KO cells, in 
order to determine the difference in the capacity of 
glutamine utilization.  Incubation of the cells in 25 mM 
unlabeled glucose and 4 mM [U-13C] glutamine for 6 hours 
on day 4 led to more active utilization of glutamine in WT 
cells than in IRS-1 KO cells (Fig. 3), consistent with the 
results from 4-day incubation in our previous report [7] and 
Figure 2.  Eight additional metabolites that are directly 
related to glutamine’s metabolic routes to fatty acid 
synthesis (glutamate, α-ketoglutarate, citrate, fumarate, 
malate, aspartate, pyruvate, and lactate) were also 
examined in WT and IRS-1 KO cells.  After 6-hr 
incubation in 25 mM unlabeled glucose and 4 mM [U-13C] 
glutamine, isotopomer distribution of the metabolites were 
measured and compared with those of wild-type cells [12] 
(Figs. 4A-4H).  Isotopomer distribution of glutamate, α-
ketoglutarate and citrate in IRS-1 KO cells were most 
distinct from that of WT cells in the fractional abundance 
of M+5 isotopomer.  M+4 isotopomers of fumarate, malate, 
aspartate of IRS-1 KO cells were remarkably higher in 
fractional abundance than those of WT cells.  In contrast, 
lactate and pyruvate of IRS-1 KO cells were not much 
different from those of WT cells in their isotopomer 
distributions, except for slightly higher M+1 isotopomer of 
pyruvate in IRS-1 KO cells.   
 
Fig. 2. Contribution of [5-13C] glutam
IRS-1 KO brown adipocytes. 
Isotopomer distribution of palmitate
brown adipocytes under incubation in
glucose and 4 mM [5-13C] glutamine f
mean ± SEM (n = 3). 
C. Assessment of goodness of fit and flux estimation  
In order to estimate the fluxes in the metabolic network 
of WT and IRS-1 KO cells on day 4 under 4 mM [U-13C] 
glutamine and 25 mM unlabeled glucose, the data for 
isotopomer distribution of nine metabolites (including 
palmitate) from WT and IRS-1 KO cells were plugged into 
the equations derived from the metabolic network (Fig. 5), 
using a MATLAB program designed for solving the 
equations with the measurements by least-square fit 
method (see “Experimental Procedures” for details).      
ine to palmitate synthesis in WT and
 isolated from WT and IRS-1 KO
 media containing 25 mM unlabeled
rom day 2 to day 6.   Data shown are
 
 










Fig. 4.  Differential incorporation of glutamine carbon into some metabolites from WT and IRS-1 KO cells. 
Isotopomer distribution of glutamate(A), alpha-ketoglutarate (B), citrate (C), fumarate (D), malate(E), aspartate(F), lactate(G), and pyruvate(H) from
WT and IRS-1 brown adipocytes on day 4 under 6-hr incubation in media containing 25 mM unlabeled glucose and 4 mM [U-13C] glutamine. Data shown
are mean ± SEM (n = 3). 
 
 
SSRES value of 56.656 (WT) and 60.294 (IRS-1 KO) were 
both within 95% confidence range of 26 – 62. 
IV. DISCUSSION 
In order to investigate in detail the effect of insulin 
signaling on the lipogenic activity specifically involving 
glutamine’s metabolic route to fatty acid synthesis, the 
fluxes of individual reactions related to the route were 
estimated through integration of isotopomer distribution 
data of nine metabolites from WT and IRS-1 KO brown 
adipocytes incubated with [U-13C] glutamine.  Since WT 
cells were shown to considerably employ reductive 
carboxylation pathway in their utilization of glutamine for 
fatty acid synthesis [7], the existence of the same pathway 
was first tested by measuring the incorporation of 13C-label 
from [5-13C] glutamine into palmitate synthesis (Fig. 3).  
Although 13C-labeling on palmitate in IRS-1 KO cells was 
not as large as in WT cells, significant amount of 13C in 
palmitate from [5-13C] glutamine indicated that reductive 
carboxylation pathway should be included in the metabolic 
network of IRS-1 KO cells.   
Uptake rate for glutamine and glucose into IRS-1 KO 
cells were measured and the relative uptake fluxes were set 
to be 100 for glutamine and 1100 for glucose.  When 
absolute glutamine uptake rates from IRS-1 KO cells and 
WT cells were compared, the ratio was 40 to 100.  
Estimated fluxes for selected reactions in the metabolic 
network for IRS-1 KO cells are summarized in Figure 6, as 
compared with those for WT cells under the same 
experimental condition [12]. 
The relative flux of reductive carboxylation reaction was 
indistinguishable between WT and IRS-1 KO cells while 
that of the reverse reaction in IRS-1 KO cells was 
approximately 3-fold higher than in WT cells.  This result 
led to net carbon flux of citrate to α-ketoglutarate being 
128 ± 4 in IRS-1 KO cells, which was also added to make 
the flux of α-ketoglutarate to succinate 6-fold higher in 
IRS-1 KO cells than in WT cells.  Glycolytic fluxes were 
comparable between WT and IRS-1 KO cells until 
pyruvate was divided into dehydrogenation (AcCoA) or 
carboxylation (OAA).  Pyruvate flux was heavily geared 
towards synthesis of acetyl-CoA in IRS-1 KO cells while it 
was more invested into carboxylation to oxaloacetate in 
WT cells.   The flux of acetyl-CoA to palmitate synthesis 
was comparable between WT cells and IRS-1 KO cells, 
indicating relatively high activity of fatty acid synthase in 
IRS-1 KO cells.  On the other hand, the flux of malate to 
pyruvate (catalyzed by malic enzyme) was 9-fold higher in 
WT cells than in IRS-1 KO cells. 
When isotopomer distribution data for nine lipogenesis-
related metabolites were compared between WT cells and 
IRS-1 KO cells under 6-hr incubation with 4 mM [U-13C] 
glutamine, the general similarity of isotopomer patterns 
also suggested that WT and IRS-1 KO cells have the same 
metabolic network with different profile of individual 
fluxes (Figs. 4A-4I).  M+5 isotopomers of glutamate, α-
ketoglutarate, and citrate were distinctively smaller in IRS-
1 KO cells than in WT cells (Figs. 4A-4C).  Because this 
isotopomer can originate from [U-13C] glutamine only 
through reductive carboxylation pathway, the smaller peaks 



































Fig. 5.  Complete metabolic network model in steady state. 
The model consists of glycolysis, fatty acid synthesis, and TCA cycle with glutamine entering at alpha-ketoglutarate via glutamate.  For the steady-
state metabolism, uptake of glucose and glutamine as well as pre-existing palmitate were regarded as inputs.  Total palmitate, protein synthesis from
aspartate, and lactate export were outputs.  The rest of the metabolites were treated as balanced except for CO2, which was allowed to be unbalanced.  
 
 
have relatively less activity of reductive carboxylation.  On 
the other hand, a common feature of the isotopomer 
distributions of fumarate, malate, and aspartate from IRS-1 
KO cells was greater abundance of M+4 isotopomer than in 
WT cells (Figs. 4D-4F).  M+4 isotopomer can be derived 
from [U-13C] glutamine via direct conversion of α-
ketoglutarate to succinate, fumarate, malate, and 
oxaloacetate along the conventional direction of TCA 
cycle.  Thus, greater abundance of M+4 isotopomer in 
fumarate, malate, and aspartate shows that IRS-1 KO cells 
have larger fluxes from α-ketoglutarate to the direction of 
succinate than WT cells. 
In order to integrate the isotopomer distribution of the 
metabolites (including palmitate) of IRS-1 KO cells into 
flux estimation, the same metabolic network as in WT cells 
were used.  Overall goodness of fit for the flux estimation 
in terms of SSRES value fell within 95% confidence range 
of SSRES values, suggesting that this flux estimation is as 
close to reality as in WT cells.  For the purpose of 
comparison between corresponding fluxes of WT and IRS-
1 KO cells, uptake fluxes of glutamine and glucose in IRS-
1 KO cells were set to be 100 and 1150 based on the 
measurement of consumption rate, although the absolute 
glutamine uptake in IRS-1 KO cells was only 40% of that 
in WT cells. Among all the estimated fluxes of WT and 
IRS-1 KO cells under standard condition, five fluxes were 
considered to be most meaningful for elucidating the 
fundamental difference in individual lipogenic fluxes (Fig. 
6).  Most distinctive was the net flux of α-ketoglutarate to 
citrate, which was a large negative flux as opposed to the 
positive net flux in WT cells.  The limited contribution of 
reductive carboxylation pathway in IRS-1 KO cells as 
shown by [5-13C] glutamine experiment (Fig. 2) was 
overcome by large flux of TCA cycle in the conventional 
direction, which was also demonstrated by 6-fold higher 
flux of α-ketoglutarate to succinate in IRS-1 KO cells.  
This result and the low D(glutamine) (fractional 
contribution of glutamine to lipogenic acetyl-CoA) of IRS-
1 KO cells [7] indicates that the extent of glutamine’s 
contribution to fatty acid synthesis depends more on the 
flux through reductive carboxylation pathway than the flux 
of conventional glutaminolysis pathway. 
 
Fig. 6.  Estimated fluxes for selected metabolic reactions in WT and IRS-1
KO brown adipocytes. 
Estimated fluxes for α-ketoglutarate to citrate (A: represented in net flux),
alpha-ketoglutarate to succinate (B), pyruvate to acetyl-CoA (C), acetyl-
CoA to palmitate (D), and malate to pyruvate (E) in WT and IRS-1 KO
brown adipocytes under incubation with 25 mM unlabeled glucose and 4
mM [U-13C] glutamine. Data shown are mean ± SEM (n=3).  
 Relatively larger flux of pyruvate to acetyl-CoA in IRS-
1 KO cells than in WT cells is consistent with D(glucose) 
(fractional contribution of glucose to lipogenic acetyl-CoA) 
in WT cells being significantly lower than that of IRS-1 
KO cells [7] because conversion of pyruvate to acetyl-CoA 
is the first committed step for glucose flux to lipogenic 
acetyl-CoA pool.  On the other hand, the relative extent of 
decrease in the flux of acetyl-CoA to palmitate (catalyzed 
by fatty acid synthase) due to absence of insulin signaling 
was not as significant despite the 9-fold smaller flux of 
malate to pyruvate via malic enzyme, which has been 
believed to heavily contribute to the supply of NADPH for 
fatty acid synthesis in brown adipose tissue [11]. 
 Taken together, the low lipogenic activity in IRS-1 KO 
cells as shown by limited fat accumulation [7][9] was 
deconvoluted into differential contribution of individual 
fluxes related to the metabolic routes of glucose and 
glutamine to fatty acid synthesis.  At least in brown 
adipocytes, lack of insulin signaling affected the lipogenic 
fluxes from glutamine to fatty acids to a greater degree than 
those from glucose to fatty acids.  Decreased contribution 
of glutamine to fatty acid synthesis was mainly due to 
relatively smaller net flux of reductive carboxylation from 
α-ketoglutarate to citrate.  Thus, together with the results 
from previous studies [12], the present study revealed that 
reductive carboxylation through NADP-dependent 
isocitrate dehydrogenase can be a critical site of regulation 
for glutamine utilization in fatty acid synthesis of adipose 
cells and its activity can be manipulated either by hormone 
(insulin) or exogenous chemicals (specific inhibitors of 
NADP-ICDH). 
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